Select a medication above to begin.
Gimoti
metoclopramide nasal
Black Box Warnings .
Tardive Dyskinesia
tx w/ metoclopramide may cause tardive dyskinesia, a serious, often irreversible movement disorder; risk incr. w/ tx duration and total cumulative dose; elderly pts, esp. elderly women, most likely to develop condition; D/C metoclopramide if s/sx tardive dyskinesia develop; avoid prolonged tx >12wk due to risk of tardive dyskinesia w/ longer-term use
Adult Dosing .
Dosage forms: SPRAY: 15 mg per actuation
diabetic gastroparesis
- [<65 yo]
- Dose: 1 actuation in one nostril qid x2-8wk; Max: 4 actuations/day; 12wk; Info: give 30min before meals and at bedtime if qid
- [65 yo and older]
- Dose: 1 actuation in one nostril qid x2-8wk; Max: 4 actuations/day; 12wk; Info: for pts stable on metoclopramide 40 mg/day PO/IM/IV; give 30min before meals and at bedtime if qid
renal dosing
- [see below]
- CrCl <60: avoid use
- HD/PD: avoid use
hepatic dosing
- [see below]
- Child-Pugh Class B or C: avoid use
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.